Your session is about to expire
← Back to Search
Anti-diabetic agent
Metformin for Osteoarthritis After ACL Surgery (PIKASO Trial)
Phase 2
Recruiting
Led By Morgan H Jones, MD, MPH
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Plan to undergo ACL reconstruction
Be between 18 and 65 years old
Must not have
Inflammatory arthritis
Known contraindication to metformin
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 3 months, 6 months, 9 months, 12 months, 18 months, 24 months
Summary
This trial will see if taking metformin can help reduce pain & delay PTOA after ACL surgery. Placebos will be used to compare results & see if the effects are due to the drug or other reasons.
Who is the study for?
This trial is for adults aged 25-45, or those 18-24 with significant preoperative knee pain, who have an ACL tear confirmed by MRI and plan to undergo reconstruction. It's not for individuals with inflammatory arthritis, kidney issues, heavy alcohol use, hepatic disease, pregnancy plans within a year, current metformin users or those with certain other knee injuries.
What is being tested?
The study tests if metformin can reduce pain and delay post-traumatic osteoarthritis after ACL surgery compared to a placebo (a pill without the drug). Metformin is known as a diabetes medication but may help due to its anti-inflammatory properties.
What are the potential side effects?
While the side effects specific to this trial are not listed here, common side effects of metformin include gastrointestinal symptoms like nausea and diarrhea. Placebos typically do not cause side effects.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am planning to have ACL reconstruction surgery.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I have inflammatory arthritis.
Select...
I cannot take metformin due to health reasons.
Select...
I am currently taking metformin or topiramate.
Select...
I have had ACL reconstruction surgery on one of my knees.
Select...
My knee X-ray shows cartilage loss and bone spurs.
Select...
I have a broken upper part of my shinbone in my knee.
Select...
I am scheduled for a transplant from a donor.
Select...
I need surgery for a knee ligament injury besides the ACL.
Select...
I am able to understand and give consent for my treatment.
Select...
My surgery is scheduled in less than 14 days from now.
Select...
I have Type 1 diabetes or have experienced diabetic ketoacidosis.
Select...
I drink heavily or have a liver disease.
Select...
I have a knee fracture that requires surgery.
Select...
I have kidney problems.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 3 months, 6 months, 9 months, 12 months, 18 months, 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 3 months, 6 months, 9 months, 12 months, 18 months, 24 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
KOOS Pain Score
Modified MOAKS Cartilage Score
Secondary study objectives
10m Habitual Walking Speed
3D Gait Biomechanics
Cartilage composition assessed with T1rho, T2
+15 moreSide effects data
From 2015 Phase 4 trial • 156 Patients • NCT0200222113%
Nasopharyngitis
10%
Hyperhidrosis
9%
Hunger
9%
Tremor
8%
Asthenia
6%
Hypoglycaemia
1%
Femoral neck fracture
1%
Squamous cell carcinoma of the tongue
100%
80%
60%
40%
20%
0%
Study treatment Arm
Vildagliptin (LAF237)
Placebo
Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: MetforminExperimental Treatment1 Intervention
3x500mg metformin hydrochloride (HCl) extended-release (ER) tablets taken orally once a day for 1 year
Group II: PlaceboPlacebo Group1 Intervention
3x metformin placebo tablets matching metformin extended-release taken orally once a day for 1 year
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Metformin
2006
Completed Phase 4
~2430
Find a Location
Who is running the clinical trial?
Brigham and Women's HospitalLead Sponsor
1,666 Previous Clinical Trials
11,839,723 Total Patients Enrolled
16 Trials studying Osteoarthritis
29,398 Patients Enrolled for Osteoarthritis
Arthritis FoundationOTHER
35 Previous Clinical Trials
45,969 Total Patients Enrolled
11 Trials studying Osteoarthritis
2,266 Patients Enrolled for Osteoarthritis
Morgan H Jones, MD, MPHPrincipal InvestigatorBrigham and Women's Hospital
Share this study with friends
Copy Link
Messenger